Illinois General Assembly - Bill Status for HB0077
Illinois General Assembly

  Bills & Resolutions  
  Compiled Statutes  
  Public Acts  
  Legislative Reports  
  IL Constitution  
  Legislative Guide  
  Legislative Glossary  

 Search By Number
 (example: HB0001)
Search Tips

Search By Keyword

 Bill Status of HB0077  104th General Assembly


Short Description:  CONTROLLED SUB-XYLAZINE

House Sponsors
Rep. Jackie Haas

Hearings
Judiciary - Criminal Committee Hearing Feb 18 2025 4:00PM Stratton Building Room D-1 Springfield, IL


Last Action
DateChamber Action
  2/4/2025HouseAssigned to Judiciary - Criminal Committee

Statutes Amended In Order of Appearance
720 ILCS 570/208from Ch. 56 1/2, par. 1208
720 ILCS 570/309.1 new


Synopsis As Introduced
Amends the Illinois Controlled Substances Act. Schedules xylazine as a Schedule III controlled substance. Provides that notwithstanding the scheduling of xylazine as a Schedule III controlled substance, xylazine shall not be considered a controlled substance when: (1) used by licensed Illinois veterinarians dispensing or prescribing for, or administering to, a nonhuman species of a drug containing xylazine that has been approved by the U.S. Food and Drug Administration; (2) used by licensed Illinois veterinarians dispensing or prescribing for, or administering to, a nonhuman species that is permissible under the Federal Food, Drug, and Cosmetic Act; (3) manufactured, distributed, or used as an active pharmaceutical ingredient for manufacturing an animal drug approved under the Federal Food, Drug, and Cosmetic Act; (4) used by a licensed certified euthanasia technician employed by a certified euthanasia agency; or (5) used by a wildlife biologist engaged in legal or authorized fieldwork under the indirect supervision of a veterinarian.

Actions 
DateChamber Action
  12/16/2024HousePrefiled with Clerk by Rep. Jackie Haas
  1/9/2025HouseFirst Reading
  1/9/2025HouseReferred to Rules Committee
  2/4/2025HouseAssigned to Judiciary - Criminal Committee

Back To Top